EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

A breakthrough Trichosporon asahii infection in an immune thrombocytopenia patient during caspofungin and isavuconazole combined therapy: a case report

Yan Lu, Yanting Sun, Yankun Li, Yingjie Wang, Dawei Wu, Zhi Li, Xi Guo

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1625007 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Yan Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Critical Care Medicine, Qilu Hospital (Qingdao), Shandong University, Qingdao, Shandong, China. Hauptthemen laut MEDLINE: Caspofungin, Antifungal Agents, Nitriles, Trichosporonosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trichosporon infection is a rare but highly lethal infectious disease. Clinically, Trichosporon asahii is the strain most commonly isolated from patients with Trichosporon infections. T. asahii is an opportunistic pathogen that can cause local or invasive infections in immunocompromised patients. In this article, a case of breakthrough T. asahii infection in an immune thrombocytopenia (ITP) patient during caspofungin and isavuconazole combined therapy is reported. Metagenomic next-generation sequencing (mNGS) played a crucial role in the diagnosis of the breakthrough infection in this patient. Upon receiving combined therapy with intravenous voriconazole and nebulized amphotericin B, the patient demonstrated significant clinical improvement and was subsequently discharged.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CaspofunginAntifungal AgentsNitrilesTrichosporonosisTriazolesTrichosporonPyridinesHumansDrug Therapy, CombinationMaleAmphotericin BTreatment OutcomeVoriconazoleImmunocompromised HostHigh-Throughput Nucleotide SequencingBasidiomycota

Stichwörter der Autor:innen

Trichosporon asahiibreakthrough invasive fungal infectionscaspofunginisavuconazolemetagenomic next-generation sequencing

Substanzen

isavuconazoleCaspofunginAntifungal AgentsNitrilesTriazolesPyridinesAmphotericin BVoriconazole

Autor:innen und Institutionen

  • Departments of Critical Care Medicine, Qilu Hospital (Qingdao), Shandong University, Qingdao, Shandong, China.

Zitieren

APA

Lu, Y., Sun, Y., Li, Y., Wang, Y., Wu, D., Li, Z., & Guo, X. (2025). A breakthrough Trichosporon asahii infection in an immune thrombocytopenia patient during caspofungin and isavuconazole combined therapy: a case report. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1625007

Vancouver

Lu Y, Sun Y, Li Y, Wang Y, Wu D, Li Z, et al. A breakthrough Trichosporon asahii infection in an immune thrombocytopenia patient during caspofungin and isavuconazole combined therapy: a case report. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1625007

BibTeX
@article{Lu2025,
  author = {Lu, Yan and Sun, Yanting and Li, Yankun and Wang, Yingjie and Wu, Dawei and Li, Zhi and Guo, Xi},
  title = {A breakthrough Trichosporon asahii infection in an immune thrombocytopenia patient during caspofungin and isavuconazole combined therapy: a case report},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1625007}
}
Kostenlos starten →